All statements other than statements of historical facts contained in this release, including statements regarding the timing of our clinical trials, our strategy, future operations, future financial ...

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography ...

Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. | Monte Rosa ...

In the turbulent heart of the Milky Way, near the supermassive black hole Sagittarius A*, astronomers have uncovered a ...

The term greenhouse gas often brings carbon dioxide (CO2) to mind, and rightly so, as it is a key contributor to rising ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes. CATT1 Phase 3 trial expected to resume following submission of protocol amendment shorten ...

Single-molecule biophysics is the study of the dynamics and interactions of individual biomolecules to understand how they carry out their functions in living cells. For example, monitoring the ...

A breakthrough in heavy-element chemistry shatters long-held assumptions about transuranium elements. Researchers have ...